Accrue Financial Group Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 1992-06-19 and was issued with the 056522822 ACN. Its Australian Business Number is 14056522822. Since 2022-07-21, the company is headquartered in QLD, post code 4034. The previous headquarters were located in QLD 4034 (from 2022-07-19 to 2022-07-21), QLD 4034 (from 2014-09-12 to 2022-07-19), and QLD 4034 (from 2009-11-20 to 2014-09-12). Accrue Financial Group Pty Ltd was registered for the GST on 2000-07-01. Accrue Financial Group Pty Ltd has been using the Accrue Financial Group Pty Ltd trading name since 2004-03-15 (it should be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 2 trading names. The above data comes from the ABN database which was updated on 2023-09-25.
Status | From | To |
---|---|---|
Active | January 15, 2000 | current |
Name | From | To |
---|---|---|
Destination Details Pty Ltd | September 25, 2023 | current |
Accrue Financial Group Pty Ltd | April 8, 2004 | September 25, 2023 |
Accrue Financial Group Pty Ltd. | December 12, 2003 | April 8, 2004 |
Stamps R Us Australia Pty. Ltd. | May 21, 2000 | December 12, 2003 |
Stamps R Us Australia P/l | January 15, 2000 | May 21, 2000 |
Name | From | To |
---|---|---|
Accrue Financial Group Pty Ltd | March 15, 2004 | current |
Stamps R Us Australia Pty Ltd | January 15, 2000 | March 15, 2004 |
Location | From | To |
---|---|---|
QLD 4034 | July 21, 2022 | current |
QLD 4034 | July 19, 2022 | July 21, 2022 |
QLD 4034 | September 12, 2014 | July 19, 2022 |
QLD 4034 | November 20, 2009 | September 12, 2014 |
QLD 4034 | August 23, 2004 | November 20, 2009 |
QLD 4151 | January 15, 2000 | August 23, 2004 |
Status | From | To |
---|---|---|
Registered | July 1, 2000 | current |
Advertisements
Register Name | AFS Representative |
AFS Representative Number | 000235609 |
Appointment status | Current |
AFS authorised representative start date | October 28, 2015 |
AFS Representative's principal business address |
Geebung QLD 4034 Australia |
Can appoint other Australian Financial Services representatives | No |
Australian Financial Services authorisations: |
Provide financial product advice Deal in a financial product/Apply for, acquire, vary or dispose of financial products on behalf of another |
AFS authorised representative will be assigned licence authorisations by the licensee | Yes |
Register Name | AFS Representative |
AFS Representative Number | 000235609 |
Appointment status | Ceased |
AFS authorised representative start date | April 20, 2011 |
AFS authorised representative end date | October 27, 2015 |
AFS Representative's principal business address |
Geebung Australia |
Can appoint other Australian Financial Services representatives | No |
Australian Financial Services authorisations: | |
AFS authorised representative will be assigned licence authorisations by the licensee | Yes |
Register Name | AFS Representative |
AFS Representative Number | 000235609 |
Appointment status | Ceased |
AFS authorised representative start date | September 1, 2003 |
AFS authorised representative end date | April 19, 2011 |
AFS Representative's principal business address |
Aspley Australia |
Can appoint other Australian Financial Services representatives | No |
Australian Financial Services authorisations: | |
AFS authorised representative will be assigned licence authorisations by the licensee | Yes |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.